| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/28/2006 | EP1280500B1 Synergistic antiplaque/antigingivitis oral composition |
| 06/28/2006 | EP1272653B1 Methods for ansamitocin production |
| 06/28/2006 | EP1224290B1 Disulfide conjugated cell toxins and methods of making and using them |
| 06/28/2006 | EP1208140B1 Rapidly decomposing chitosan-based pellets |
| 06/28/2006 | EP1173517A4 In situ forming hydrogels |
| 06/28/2006 | EP1156789B9 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 06/28/2006 | EP1154767B9 Substituted stilbene compounds with vascular damaging activity |
| 06/28/2006 | EP1107762B9 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure sexual dysfunction in women |
| 06/28/2006 | EP1073439B1 Pharmaceutical composition |
| 06/28/2006 | EP1025859B1 Powdery pernasal compositions |
| 06/28/2006 | EP1017364A4 Inorganic-polymer complexes for the controlled release of compounds including medicinals |
| 06/28/2006 | EP0895543B1 Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
| 06/28/2006 | EP0820307B1 Increasing the hdl level and the hdl/ldl ratio in human serum by balancing saturated and polyunsaturated dietary fatty acids |
| 06/28/2006 | CN1795214A Higher molecular modifier and medicinal composition |
| 06/28/2006 | CN1795014A Method for the preparation of molecular complexes |
| 06/28/2006 | CN1795013A Compositions for treating infection in cattle and swine |
| 06/28/2006 | CN1795012A Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 06/28/2006 | CN1794998A Foamable pharmaceutical compositions and methods for treating a disorder |
| 06/28/2006 | CN1794993A Medicinal composition containing benidipine hydrochloride |
| 06/28/2006 | CN1794983A Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 06/28/2006 | CN1794976A Dietary supplement and method for the treatment and prevention of digestive tract ulcers in equines and other animals |
| 06/28/2006 | CN1794915A Aqueous compositions for disinfection and/or sterilization |
| 06/28/2006 | CN1793209A Polyelectrolyte polysaccharose nano paticle and preparation process thereof |
| 06/28/2006 | CN1793197A Process for preparing magnetic composite microball of monomer synthesizing biological degradable polyester kind |
| 06/28/2006 | CN1792364A Medicinal composition contg. stavudine and valproic acid or salts thereof |
| 06/28/2006 | CN1792363A Medicinal composition contg. IDV and valproic acid or salts thereof |
| 06/28/2006 | CN1261164C Medicine for burn and scald and its preparation |
| 06/28/2006 | CN1261163C Stabilization of macrolides |
| 06/28/2006 | CN1261101C Chitosan glycyrrhizie acid nano particle and its preparing method |
| 06/28/2006 | CN1261094C New use of lipase inhibitors |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | USRE39149 Method of administering azithromycin |
| 06/27/2006 | US7067698 Preparation of preferential oligomers for use as therapeutic tools; obtain oligomer, incubate with amines, expose to guanidinylation reagent, recover oligomer |
| 06/27/2006 | US7067639 Method to provide bacterial ghosts provided with antigens |
| 06/27/2006 | US7067618 reaction product of a peptide (e.g., an insulin or enkephalin) with a lactose or sialyllactose reducing sugar and optionally reacting the product with polyoxyethylene, polyglutamic acid or polyvinylpyrrolidone; peptide is released in response to pH change; improved in vivo durability of targeted drugs |
| 06/27/2006 | US7067555 Sertraline oral concentrate |
| 06/27/2006 | US7067508 Diaminedithiol derivatives and radiorhenium or radiotechnetium complex thereof; a liver cancer-treating composition comprising the radiorhenium complex and lipiodol; and a kit for preparation of the liver cancer-treating composition |
| 06/27/2006 | US7067498 Feeding low viscosity fiber and starch hydrolyzates; antidiabetic agents |
| 06/27/2006 | US7067483 Pharmaceutical compositions containing a gycopeptide antibiotic and a cyclodextrin |
| 06/27/2006 | US7067308 Vector for genetically modifying non-human animals |
| 06/27/2006 | US7067158 Preparation for the relief of disease |
| 06/27/2006 | US7067154 Pharmaceutical compositions containing Vitamin D and calcium, their preparation and therapeutic use |
| 06/27/2006 | US7067153 Microcapsule powder |
| 06/27/2006 | US7067149 Coated active materials; carrier mixtureof disintegrating agent, diluent , lubricant , flavors, coloring, sweetening and binder; compression |
| 06/27/2006 | US7067148 Levothyroxine sodium and liothyronine sodium in solid form with microcrystalline cellulose; treating hypothyroidism and thyroid hormone replacement therapy |
| 06/27/2006 | US7067147 Hypoallergenic dietary companion animal composition containing hydrolyzed poultry protein |
| 06/27/2006 | US7067146 Food compositions and methods of preparing the same |
| 06/27/2006 | US7067145 Administering to larvae in a nutritional diet essential fatty acids including docosahexaenoic acid and arachidonic acid to enhanceculturing characteristic of fish larvae |
| 06/27/2006 | US7067144 Compositions and methods for systemic inhibition of cartilage degradation |
| 06/27/2006 | US7067143 Premixed amiodarone parenteral solution and method for making the same |
| 06/27/2006 | US7067132 Binding to muteins; prevent signal transduction; monoclonal antibodies; graft versus host disease; antiarthritic agents; antidiabetic agents; skin disorders; autoimmune disease; inflammatory bowel disorders; anticancer agents |
| 06/27/2006 | US7067131 Methods for using anti-MUC18 antibodies |
| 06/27/2006 | US7067129 Receptor specific transepithelial transport in therapeutics |
| 06/27/2006 | US7067128 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 06/27/2006 | US7067119 Using polypeptides |
| 06/27/2006 | US7067116 Mixture of water soluble film forming polymer such as pullulan , dextromethorphan and an ion exchange resin such as Amberlite |
| 06/27/2006 | US7067114 Delivery of antihistamines through an inhalation route |
| 06/27/2006 | US7067109 Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
| 06/27/2006 | US7067061 Method and a device for preparing a medical liquid |
| 06/27/2006 | CA2455971C Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| 06/27/2006 | CA2394506C Adhesive preparations |
| 06/27/2006 | CA2315784C Tts containing an antioxidant |
| 06/24/2006 | CA2488807A1 White ointment |
| 06/22/2006 | WO2006065947A1 Method for treatment of hiv infection |
| 06/22/2006 | WO2006065920A1 Anti-aging methods and composition |
| 06/22/2006 | WO2006065861A2 Therapeutic formulations of keratinocyte growth factor |
| 06/22/2006 | WO2006065746A2 Methods of treating ige-mediated disorders comprising the administration of high concentration anti-ige antibody formulations |
| 06/22/2006 | WO2006065136A1 Water-dispersible xanthan gum containing composition |
| 06/22/2006 | WO2006064906A1 Amorphous composition |
| 06/22/2006 | WO2006064747A1 Medical tape preparation |
| 06/22/2006 | WO2006064539A1 Reducing physiological saline solutions and process for the production thereof |
| 06/22/2006 | WO2006063821A1 Manufacture process of n-substituted salicylamides |
| 06/22/2006 | WO2006063506A1 Utilization for carbon nanosphere in anti-cancer medicine |
| 06/22/2006 | WO2006051572A3 Method for controlling the dimensions and the morphology of nanostructural polymeric materials, materials thereby obtained and uses thereof |
| 06/22/2006 | WO2006042269A3 Lipopolymer conjugates |
| 06/22/2006 | WO2006040047A3 Diagnostics and therapeutics for diseases associated with rho/rac-interacting citron kinase (cit) |
| 06/22/2006 | WO2006038184A3 Compounds, kits and methods for use in medical imaging |
| 06/22/2006 | WO2006017727A3 Glycosides and salts thereof |
| 06/22/2006 | WO2006008008A3 Diagnostics and therapeutics for diseases associated with hepatocyte nuclear factor 4, alpha (hnf4a) |
| 06/22/2006 | WO2005123135A8 Stabilized compositions comprising a therapeutically active agent, citric acid or a conjugated base and chlorine dioxide |
| 06/22/2006 | WO2005113005A3 Transcutaneous and/or transdermal transport of materials |
| 06/22/2006 | WO2005101004A8 Diagnostics and therapeutics for diseases associated with purinoceptor 1 type y (p2y1) |
| 06/22/2006 | WO2005094897A3 Pegylated ion channel modulating compounds |
| 06/22/2006 | WO2005055924A3 Skin adherent hydrogels |
| 06/22/2006 | WO2004056318A8 Method for treating amyloid disease |
| 06/22/2006 | US20060135749 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 06/22/2006 | US20060135473 Lyophilization or freeze drying the piroxicam:beta-cyclodextrin inclusion compound by dissolving and heating the two components in an aqueous solution of of ammonium hydroxide; freeze drying; vacuum drying; water soluble amorphous product with high bioavailability; industrial scale |
| 06/22/2006 | US20060135464 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues |
| 06/22/2006 | US20060135454 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 06/22/2006 | US20060135453 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 06/22/2006 | US20060135434 New peptides |
| 06/22/2006 | US20060135410 Targeted delivery to legumain-expressing cells |
| 06/22/2006 | US20060135404 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/22/2006 | US20060135402 in combination with oral delivery agent such as N-(5-chlorosalicyloyl)8-aminocaprylic acid (5-CNAC), N-10-[2-hydroxybenzoyl]aminodecanoic acid (SNAD) or N-(8-[2-hydroxybenzoyl]amino)caprylic acid (SNAC), or their disodium salts to improve bioavailability |
| 06/22/2006 | US20060134595 Polymer affinity matrix, a method for the production and use thereof |
| 06/22/2006 | US20060134223 Process for producing microparticles |
| 06/22/2006 | US20060134220 Vectorization system comprising nanoparticles of homogenous size of at least one polymer and at least one positively charged polysaccharide and method for the preparation thereof |
| 06/22/2006 | US20060134208 Controlled release and taste masking oral pharmaceutical composition |
| 06/22/2006 | US20060134205 Process for preparing a pharmaceutical composition |
| 06/22/2006 | US20060134203 a water insoluble drug (a cyclosporin or macrolides), a solubilizer, and a surfactant; improved stability, and bioavailability; immunosuppressants |